Global Quetiapine Fumarate Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Quetiapine Fumarate market size is predicted to grow from US$ 147 million in 2025 to US$ 128 million in 2031; it is expected to grow at a CAGR of -2.3% from 2025 to 2031.
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
LP Information, Inc. (LPI) ' newest research report, the “Quetiapine Fumarate Industry Forecast” looks at past sales and reviews total world Quetiapine Fumarate sales in 2024, providing a comprehensive analysis by region and market sector of projected Quetiapine Fumarate sales for 2025 through 2031. With Quetiapine Fumarate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Quetiapine Fumarate industry.
This Insight Report provides a comprehensive analysis of the global Quetiapine Fumarate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Quetiapine Fumarate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Quetiapine Fumarate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Quetiapine Fumarate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Quetiapine Fumarate.
This report presents a comprehensive overview, market shares, and growth opportunities of Quetiapine Fumarate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Quetiapine Fumarate market?
What factors are driving Quetiapine Fumarate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Quetiapine Fumarate market opportunities vary by end market size?
How does Quetiapine Fumarate break out by Type, by Application?
The global Quetiapine Fumarate market size is predicted to grow from US$ 147 million in 2025 to US$ 128 million in 2031; it is expected to grow at a CAGR of -2.3% from 2025 to 2031.
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
LP Information, Inc. (LPI) ' newest research report, the “Quetiapine Fumarate Industry Forecast” looks at past sales and reviews total world Quetiapine Fumarate sales in 2024, providing a comprehensive analysis by region and market sector of projected Quetiapine Fumarate sales for 2025 through 2031. With Quetiapine Fumarate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Quetiapine Fumarate industry.
This Insight Report provides a comprehensive analysis of the global Quetiapine Fumarate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Quetiapine Fumarate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Quetiapine Fumarate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Quetiapine Fumarate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Quetiapine Fumarate.
This report presents a comprehensive overview, market shares, and growth opportunities of Quetiapine Fumarate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Immediate Release Tablets
- Extended Release Tablets
- Adult
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Intas
- TAPI
- Accord
- Hexal
- Dr.Reddy's
- Lupin
- Sun Pharmaceutical
- Hunan Dongting Pharm
- SuZhou NO.4 Phamaceutical Factory
- Fuan Pharmaceutical
- Zhejiang Supor Pharmaceuticals
- Zhejiang Huahai Pharmaceutical
What is the 10-year outlook for the global Quetiapine Fumarate market?
What factors are driving Quetiapine Fumarate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Quetiapine Fumarate market opportunities vary by end market size?
How does Quetiapine Fumarate break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Quetiapine Fumarate Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Quetiapine Fumarate by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Quetiapine Fumarate by Country/Region, 2020, 2024 & 2031
2.2 Quetiapine Fumarate Segment by Type
2.2.1 Immediate Release Tablets
2.2.2 Extended Release Tablets
2.3 Quetiapine Fumarate Sales by Type
2.3.1 Global Quetiapine Fumarate Sales Market Share by Type (2020-2025)
2.3.2 Global Quetiapine Fumarate Revenue and Market Share by Type (2020-2025)
2.3.3 Global Quetiapine Fumarate Sale Price by Type (2020-2025)
2.4 Quetiapine Fumarate Segment by Application
2.4.1 Adult
2.4.2 Others
2.5 Quetiapine Fumarate Sales by Application
2.5.1 Global Quetiapine Fumarate Sale Market Share by Application (2020-2025)
2.5.2 Global Quetiapine Fumarate Revenue and Market Share by Application (2020-2025)
2.5.3 Global Quetiapine Fumarate Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Quetiapine Fumarate Breakdown Data by Company
3.1.1 Global Quetiapine Fumarate Annual Sales by Company (2020-2025)
3.1.2 Global Quetiapine Fumarate Sales Market Share by Company (2020-2025)
3.2 Global Quetiapine Fumarate Annual Revenue by Company (2020-2025)
3.2.1 Global Quetiapine Fumarate Revenue by Company (2020-2025)
3.2.2 Global Quetiapine Fumarate Revenue Market Share by Company (2020-2025)
3.3 Global Quetiapine Fumarate Sale Price by Company
3.4 Key Manufacturers Quetiapine Fumarate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Quetiapine Fumarate Product Location Distribution
3.4.2 Players Quetiapine Fumarate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR QUETIAPINE FUMARATE BY GEOGRAPHIC REGION
4.1 World Historic Quetiapine Fumarate Market Size by Geographic Region (2020-2025)
4.1.1 Global Quetiapine Fumarate Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Quetiapine Fumarate Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Quetiapine Fumarate Market Size by Country/Region (2020-2025)
4.2.1 Global Quetiapine Fumarate Annual Sales by Country/Region (2020-2025)
4.2.2 Global Quetiapine Fumarate Annual Revenue by Country/Region (2020-2025)
4.3 Americas Quetiapine Fumarate Sales Growth
4.4 APAC Quetiapine Fumarate Sales Growth
4.5 Europe Quetiapine Fumarate Sales Growth
4.6 Middle East & Africa Quetiapine Fumarate Sales Growth
5 AMERICAS
5.1 Americas Quetiapine Fumarate Sales by Country
5.1.1 Americas Quetiapine Fumarate Sales by Country (2020-2025)
5.1.2 Americas Quetiapine Fumarate Revenue by Country (2020-2025)
5.2 Americas Quetiapine Fumarate Sales by Type (2020-2025)
5.3 Americas Quetiapine Fumarate Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Quetiapine Fumarate Sales by Region
6.1.1 APAC Quetiapine Fumarate Sales by Region (2020-2025)
6.1.2 APAC Quetiapine Fumarate Revenue by Region (2020-2025)
6.2 APAC Quetiapine Fumarate Sales by Type (2020-2025)
6.3 APAC Quetiapine Fumarate Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Quetiapine Fumarate by Country
7.1.1 Europe Quetiapine Fumarate Sales by Country (2020-2025)
7.1.2 Europe Quetiapine Fumarate Revenue by Country (2020-2025)
7.2 Europe Quetiapine Fumarate Sales by Type (2020-2025)
7.3 Europe Quetiapine Fumarate Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Quetiapine Fumarate by Country
8.1.1 Middle East & Africa Quetiapine Fumarate Sales by Country (2020-2025)
8.1.2 Middle East & Africa Quetiapine Fumarate Revenue by Country (2020-2025)
8.2 Middle East & Africa Quetiapine Fumarate Sales by Type (2020-2025)
8.3 Middle East & Africa Quetiapine Fumarate Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Quetiapine Fumarate
10.3 Manufacturing Process Analysis of Quetiapine Fumarate
10.4 Industry Chain Structure of Quetiapine Fumarate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Quetiapine Fumarate Distributors
11.3 Quetiapine Fumarate Customer
12 WORLD FORECAST REVIEW FOR QUETIAPINE FUMARATE BY GEOGRAPHIC REGION
12.1 Global Quetiapine Fumarate Market Size Forecast by Region
12.1.1 Global Quetiapine Fumarate Forecast by Region (2026-2031)
12.1.2 Global Quetiapine Fumarate Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Quetiapine Fumarate Forecast by Type (2026-2031)
12.7 Global Quetiapine Fumarate Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Quetiapine Fumarate Product Portfolios and Specifications
13.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Intas
13.2.1 Intas Company Information
13.2.2 Intas Quetiapine Fumarate Product Portfolios and Specifications
13.2.3 Intas Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Intas Main Business Overview
13.2.5 Intas Latest Developments
13.3 TAPI
13.3.1 TAPI Company Information
13.3.2 TAPI Quetiapine Fumarate Product Portfolios and Specifications
13.3.3 TAPI Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 TAPI Main Business Overview
13.3.5 TAPI Latest Developments
13.4 Accord
13.4.1 Accord Company Information
13.4.2 Accord Quetiapine Fumarate Product Portfolios and Specifications
13.4.3 Accord Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Accord Main Business Overview
13.4.5 Accord Latest Developments
13.5 Hexal
13.5.1 Hexal Company Information
13.5.2 Hexal Quetiapine Fumarate Product Portfolios and Specifications
13.5.3 Hexal Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hexal Main Business Overview
13.5.5 Hexal Latest Developments
13.6 Dr.Reddy's
13.6.1 Dr.Reddy's Company Information
13.6.2 Dr.Reddy's Quetiapine Fumarate Product Portfolios and Specifications
13.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dr.Reddy's Main Business Overview
13.6.5 Dr.Reddy's Latest Developments
13.7 Lupin
13.7.1 Lupin Company Information
13.7.2 Lupin Quetiapine Fumarate Product Portfolios and Specifications
13.7.3 Lupin Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lupin Main Business Overview
13.7.5 Lupin Latest Developments
13.8 Sun Pharmaceutical
13.8.1 Sun Pharmaceutical Company Information
13.8.2 Sun Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
13.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sun Pharmaceutical Main Business Overview
13.8.5 Sun Pharmaceutical Latest Developments
13.9 Hunan Dongting Pharm
13.9.1 Hunan Dongting Pharm Company Information
13.9.2 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolios and Specifications
13.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hunan Dongting Pharm Main Business Overview
13.9.5 Hunan Dongting Pharm Latest Developments
13.10 SuZhou NO.4 Phamaceutical Factory
13.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
13.10.2 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolios and Specifications
13.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 SuZhou NO.4 Phamaceutical Factory Main Business Overview
13.10.5 SuZhou NO.4 Phamaceutical Factory Latest Developments
13.11 Fuan Pharmaceutical
13.11.1 Fuan Pharmaceutical Company Information
13.11.2 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
13.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Fuan Pharmaceutical Main Business Overview
13.11.5 Fuan Pharmaceutical Latest Developments
13.12 Zhejiang Supor Pharmaceuticals
13.12.1 Zhejiang Supor Pharmaceuticals Company Information
13.12.2 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolios and Specifications
13.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Zhejiang Supor Pharmaceuticals Main Business Overview
13.12.5 Zhejiang Supor Pharmaceuticals Latest Developments
13.13 Zhejiang Huahai Pharmaceutical
13.13.1 Zhejiang Huahai Pharmaceutical Company Information
13.13.2 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
13.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.13.5 Zhejiang Huahai Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Quetiapine Fumarate Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Quetiapine Fumarate by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Quetiapine Fumarate by Country/Region, 2020, 2024 & 2031
2.2 Quetiapine Fumarate Segment by Type
2.2.1 Immediate Release Tablets
2.2.2 Extended Release Tablets
2.3 Quetiapine Fumarate Sales by Type
2.3.1 Global Quetiapine Fumarate Sales Market Share by Type (2020-2025)
2.3.2 Global Quetiapine Fumarate Revenue and Market Share by Type (2020-2025)
2.3.3 Global Quetiapine Fumarate Sale Price by Type (2020-2025)
2.4 Quetiapine Fumarate Segment by Application
2.4.1 Adult
2.4.2 Others
2.5 Quetiapine Fumarate Sales by Application
2.5.1 Global Quetiapine Fumarate Sale Market Share by Application (2020-2025)
2.5.2 Global Quetiapine Fumarate Revenue and Market Share by Application (2020-2025)
2.5.3 Global Quetiapine Fumarate Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Quetiapine Fumarate Breakdown Data by Company
3.1.1 Global Quetiapine Fumarate Annual Sales by Company (2020-2025)
3.1.2 Global Quetiapine Fumarate Sales Market Share by Company (2020-2025)
3.2 Global Quetiapine Fumarate Annual Revenue by Company (2020-2025)
3.2.1 Global Quetiapine Fumarate Revenue by Company (2020-2025)
3.2.2 Global Quetiapine Fumarate Revenue Market Share by Company (2020-2025)
3.3 Global Quetiapine Fumarate Sale Price by Company
3.4 Key Manufacturers Quetiapine Fumarate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Quetiapine Fumarate Product Location Distribution
3.4.2 Players Quetiapine Fumarate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR QUETIAPINE FUMARATE BY GEOGRAPHIC REGION
4.1 World Historic Quetiapine Fumarate Market Size by Geographic Region (2020-2025)
4.1.1 Global Quetiapine Fumarate Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Quetiapine Fumarate Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Quetiapine Fumarate Market Size by Country/Region (2020-2025)
4.2.1 Global Quetiapine Fumarate Annual Sales by Country/Region (2020-2025)
4.2.2 Global Quetiapine Fumarate Annual Revenue by Country/Region (2020-2025)
4.3 Americas Quetiapine Fumarate Sales Growth
4.4 APAC Quetiapine Fumarate Sales Growth
4.5 Europe Quetiapine Fumarate Sales Growth
4.6 Middle East & Africa Quetiapine Fumarate Sales Growth
5 AMERICAS
5.1 Americas Quetiapine Fumarate Sales by Country
5.1.1 Americas Quetiapine Fumarate Sales by Country (2020-2025)
5.1.2 Americas Quetiapine Fumarate Revenue by Country (2020-2025)
5.2 Americas Quetiapine Fumarate Sales by Type (2020-2025)
5.3 Americas Quetiapine Fumarate Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Quetiapine Fumarate Sales by Region
6.1.1 APAC Quetiapine Fumarate Sales by Region (2020-2025)
6.1.2 APAC Quetiapine Fumarate Revenue by Region (2020-2025)
6.2 APAC Quetiapine Fumarate Sales by Type (2020-2025)
6.3 APAC Quetiapine Fumarate Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Quetiapine Fumarate by Country
7.1.1 Europe Quetiapine Fumarate Sales by Country (2020-2025)
7.1.2 Europe Quetiapine Fumarate Revenue by Country (2020-2025)
7.2 Europe Quetiapine Fumarate Sales by Type (2020-2025)
7.3 Europe Quetiapine Fumarate Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Quetiapine Fumarate by Country
8.1.1 Middle East & Africa Quetiapine Fumarate Sales by Country (2020-2025)
8.1.2 Middle East & Africa Quetiapine Fumarate Revenue by Country (2020-2025)
8.2 Middle East & Africa Quetiapine Fumarate Sales by Type (2020-2025)
8.3 Middle East & Africa Quetiapine Fumarate Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Quetiapine Fumarate
10.3 Manufacturing Process Analysis of Quetiapine Fumarate
10.4 Industry Chain Structure of Quetiapine Fumarate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Quetiapine Fumarate Distributors
11.3 Quetiapine Fumarate Customer
12 WORLD FORECAST REVIEW FOR QUETIAPINE FUMARATE BY GEOGRAPHIC REGION
12.1 Global Quetiapine Fumarate Market Size Forecast by Region
12.1.1 Global Quetiapine Fumarate Forecast by Region (2026-2031)
12.1.2 Global Quetiapine Fumarate Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Quetiapine Fumarate Forecast by Type (2026-2031)
12.7 Global Quetiapine Fumarate Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Quetiapine Fumarate Product Portfolios and Specifications
13.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Intas
13.2.1 Intas Company Information
13.2.2 Intas Quetiapine Fumarate Product Portfolios and Specifications
13.2.3 Intas Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Intas Main Business Overview
13.2.5 Intas Latest Developments
13.3 TAPI
13.3.1 TAPI Company Information
13.3.2 TAPI Quetiapine Fumarate Product Portfolios and Specifications
13.3.3 TAPI Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 TAPI Main Business Overview
13.3.5 TAPI Latest Developments
13.4 Accord
13.4.1 Accord Company Information
13.4.2 Accord Quetiapine Fumarate Product Portfolios and Specifications
13.4.3 Accord Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Accord Main Business Overview
13.4.5 Accord Latest Developments
13.5 Hexal
13.5.1 Hexal Company Information
13.5.2 Hexal Quetiapine Fumarate Product Portfolios and Specifications
13.5.3 Hexal Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hexal Main Business Overview
13.5.5 Hexal Latest Developments
13.6 Dr.Reddy's
13.6.1 Dr.Reddy's Company Information
13.6.2 Dr.Reddy's Quetiapine Fumarate Product Portfolios and Specifications
13.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dr.Reddy's Main Business Overview
13.6.5 Dr.Reddy's Latest Developments
13.7 Lupin
13.7.1 Lupin Company Information
13.7.2 Lupin Quetiapine Fumarate Product Portfolios and Specifications
13.7.3 Lupin Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lupin Main Business Overview
13.7.5 Lupin Latest Developments
13.8 Sun Pharmaceutical
13.8.1 Sun Pharmaceutical Company Information
13.8.2 Sun Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
13.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sun Pharmaceutical Main Business Overview
13.8.5 Sun Pharmaceutical Latest Developments
13.9 Hunan Dongting Pharm
13.9.1 Hunan Dongting Pharm Company Information
13.9.2 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolios and Specifications
13.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hunan Dongting Pharm Main Business Overview
13.9.5 Hunan Dongting Pharm Latest Developments
13.10 SuZhou NO.4 Phamaceutical Factory
13.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
13.10.2 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolios and Specifications
13.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 SuZhou NO.4 Phamaceutical Factory Main Business Overview
13.10.5 SuZhou NO.4 Phamaceutical Factory Latest Developments
13.11 Fuan Pharmaceutical
13.11.1 Fuan Pharmaceutical Company Information
13.11.2 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
13.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Fuan Pharmaceutical Main Business Overview
13.11.5 Fuan Pharmaceutical Latest Developments
13.12 Zhejiang Supor Pharmaceuticals
13.12.1 Zhejiang Supor Pharmaceuticals Company Information
13.12.2 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolios and Specifications
13.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Zhejiang Supor Pharmaceuticals Main Business Overview
13.12.5 Zhejiang Supor Pharmaceuticals Latest Developments
13.13 Zhejiang Huahai Pharmaceutical
13.13.1 Zhejiang Huahai Pharmaceutical Company Information
13.13.2 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
13.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.13.5 Zhejiang Huahai Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Quetiapine Fumarate Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Quetiapine Fumarate Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immediate Release Tablets
Table 4. Major Players of Extended Release Tablets
Table 5. Global Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 6. Global Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Table 7. Global Quetiapine Fumarate Revenue by Type (2020-2025) & ($ million)
Table 8. Global Quetiapine Fumarate Revenue Market Share by Type (2020-2025)
Table 9. Global Quetiapine Fumarate Sale Price by Type (2020-2025) & (USD/Kg)
Table 10. Global Quetiapine Fumarate Sale by Application (2020-2025) & (MT)
Table 11. Global Quetiapine Fumarate Sale Market Share by Application (2020-2025)
Table 12. Global Quetiapine Fumarate Revenue by Application (2020-2025) & ($ million)
Table 13. Global Quetiapine Fumarate Revenue Market Share by Application (2020-2025)
Table 14. Global Quetiapine Fumarate Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Quetiapine Fumarate Sales by Company (2020-2025) & (MT)
Table 16. Global Quetiapine Fumarate Sales Market Share by Company (2020-2025)
Table 17. Global Quetiapine Fumarate Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Quetiapine Fumarate Revenue Market Share by Company (2020-2025)
Table 19. Global Quetiapine Fumarate Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Quetiapine Fumarate Producing Area Distribution and Sales Area
Table 21. Players Quetiapine Fumarate Products Offered
Table 22. Quetiapine Fumarate Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Quetiapine Fumarate Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Quetiapine Fumarate Sales Market Share Geographic Region (2020-2025)
Table 27. Global Quetiapine Fumarate Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Quetiapine Fumarate Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Quetiapine Fumarate Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Quetiapine Fumarate Sales Market Share by Country/Region (2020-2025)
Table 31. Global Quetiapine Fumarate Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Quetiapine Fumarate Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 34. Americas Quetiapine Fumarate Sales Market Share by Country (2020-2025)
Table 35. Americas Quetiapine Fumarate Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 37. Americas Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 38. APAC Quetiapine Fumarate Sales by Region (2020-2025) & (MT)
Table 39. APAC Quetiapine Fumarate Sales Market Share by Region (2020-2025)
Table 40. APAC Quetiapine Fumarate Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 42. APAC Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 43. Europe Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 44. Europe Quetiapine Fumarate Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 46. Europe Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Quetiapine Fumarate Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 50. Middle East & Africa Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Quetiapine Fumarate
Table 52. Key Market Challenges & Risks of Quetiapine Fumarate
Table 53. Key Industry Trends of Quetiapine Fumarate
Table 54. Quetiapine Fumarate Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Quetiapine Fumarate Distributors List
Table 57. Quetiapine Fumarate Customer List
Table 58. Global Quetiapine Fumarate Sales Forecast by Region (2026-2031) & (MT)
Table 59. Global Quetiapine Fumarate Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Quetiapine Fumarate Sales Forecast by Country (2026-2031) & (MT)
Table 61. Americas Quetiapine Fumarate Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Quetiapine Fumarate Sales Forecast by Region (2026-2031) & (MT)
Table 63. APAC Quetiapine Fumarate Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Quetiapine Fumarate Sales Forecast by Country (2026-2031) & (MT)
Table 65. Europe Quetiapine Fumarate Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Quetiapine Fumarate Sales Forecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Quetiapine Fumarate Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Quetiapine Fumarate Sales Forecast by Type (2026-2031) & (MT)
Table 69. Global Quetiapine Fumarate Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Quetiapine Fumarate Sales Forecast by Application (2026-2031) & (MT)
Table 71. Global Quetiapine Fumarate Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. AstraZeneca Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 73. AstraZeneca Quetiapine Fumarate Product Portfolios and Specifications
Table 74. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. AstraZeneca Main Business
Table 76. AstraZeneca Latest Developments
Table 77. Intas Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 78. Intas Quetiapine Fumarate Product Portfolios and Specifications
Table 79. Intas Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Intas Main Business
Table 81. Intas Latest Developments
Table 82. TAPI Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 83. TAPI Quetiapine Fumarate Product Portfolios and Specifications
Table 84. TAPI Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. TAPI Main Business
Table 86. TAPI Latest Developments
Table 87. Accord Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 88. Accord Quetiapine Fumarate Product Portfolios and Specifications
Table 89. Accord Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Accord Main Business
Table 91. Accord Latest Developments
Table 92. Hexal Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 93. Hexal Quetiapine Fumarate Product Portfolios and Specifications
Table 94. Hexal Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95. Hexal Main Business
Table 96. Hexal Latest Developments
Table 97. Dr.Reddy's Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 98. Dr.Reddy's Quetiapine Fumarate Product Portfolios and Specifications
Table 99. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. Dr.Reddy's Main Business
Table 101. Dr.Reddy's Latest Developments
Table 102. Lupin Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 103. Lupin Quetiapine Fumarate Product Portfolios and Specifications
Table 104. Lupin Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Lupin Main Business
Table 106. Lupin Latest Developments
Table 107. Sun Pharmaceutical Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
Table 109. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. Sun Pharmaceutical Main Business
Table 111. Sun Pharmaceutical Latest Developments
Table 112. Hunan Dongting Pharm Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 113. Hunan Dongting Pharm Quetiapine Fumarate Product Portfolios and Specifications
Table 114. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. Hunan Dongting Pharm Main Business
Table 116. Hunan Dongting Pharm Latest Developments
Table 117. SuZhou NO.4 Phamaceutical Factory Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 118. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolios and Specifications
Table 119. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. SuZhou NO.4 Phamaceutical Factory Main Business
Table 121. SuZhou NO.4 Phamaceutical Factory Latest Developments
Table 122. Fuan Pharmaceutical Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 123. Fuan Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
Table 124. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. Fuan Pharmaceutical Main Business
Table 126. Fuan Pharmaceutical Latest Developments
Table 127. Zhejiang Supor Pharmaceuticals Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 128. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolios and Specifications
Table 129. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 130. Zhejiang Supor Pharmaceuticals Main Business
Table 131. Zhejiang Supor Pharmaceuticals Latest Developments
Table 132. Zhejiang Huahai Pharmaceutical Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 133. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
Table 134. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 135. Zhejiang Huahai Pharmaceutical Main Business
Table 136. Zhejiang Huahai Pharmaceutical Latest Developments
Table 1. Quetiapine Fumarate Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Quetiapine Fumarate Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immediate Release Tablets
Table 4. Major Players of Extended Release Tablets
Table 5. Global Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 6. Global Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Table 7. Global Quetiapine Fumarate Revenue by Type (2020-2025) & ($ million)
Table 8. Global Quetiapine Fumarate Revenue Market Share by Type (2020-2025)
Table 9. Global Quetiapine Fumarate Sale Price by Type (2020-2025) & (USD/Kg)
Table 10. Global Quetiapine Fumarate Sale by Application (2020-2025) & (MT)
Table 11. Global Quetiapine Fumarate Sale Market Share by Application (2020-2025)
Table 12. Global Quetiapine Fumarate Revenue by Application (2020-2025) & ($ million)
Table 13. Global Quetiapine Fumarate Revenue Market Share by Application (2020-2025)
Table 14. Global Quetiapine Fumarate Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Quetiapine Fumarate Sales by Company (2020-2025) & (MT)
Table 16. Global Quetiapine Fumarate Sales Market Share by Company (2020-2025)
Table 17. Global Quetiapine Fumarate Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Quetiapine Fumarate Revenue Market Share by Company (2020-2025)
Table 19. Global Quetiapine Fumarate Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Quetiapine Fumarate Producing Area Distribution and Sales Area
Table 21. Players Quetiapine Fumarate Products Offered
Table 22. Quetiapine Fumarate Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Quetiapine Fumarate Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Quetiapine Fumarate Sales Market Share Geographic Region (2020-2025)
Table 27. Global Quetiapine Fumarate Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Quetiapine Fumarate Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Quetiapine Fumarate Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Quetiapine Fumarate Sales Market Share by Country/Region (2020-2025)
Table 31. Global Quetiapine Fumarate Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Quetiapine Fumarate Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 34. Americas Quetiapine Fumarate Sales Market Share by Country (2020-2025)
Table 35. Americas Quetiapine Fumarate Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 37. Americas Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 38. APAC Quetiapine Fumarate Sales by Region (2020-2025) & (MT)
Table 39. APAC Quetiapine Fumarate Sales Market Share by Region (2020-2025)
Table 40. APAC Quetiapine Fumarate Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 42. APAC Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 43. Europe Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 44. Europe Quetiapine Fumarate Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 46. Europe Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Quetiapine Fumarate Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Quetiapine Fumarate Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Quetiapine Fumarate Sales by Type (2020-2025) & (MT)
Table 50. Middle East & Africa Quetiapine Fumarate Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Quetiapine Fumarate
Table 52. Key Market Challenges & Risks of Quetiapine Fumarate
Table 53. Key Industry Trends of Quetiapine Fumarate
Table 54. Quetiapine Fumarate Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Quetiapine Fumarate Distributors List
Table 57. Quetiapine Fumarate Customer List
Table 58. Global Quetiapine Fumarate Sales Forecast by Region (2026-2031) & (MT)
Table 59. Global Quetiapine Fumarate Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Quetiapine Fumarate Sales Forecast by Country (2026-2031) & (MT)
Table 61. Americas Quetiapine Fumarate Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Quetiapine Fumarate Sales Forecast by Region (2026-2031) & (MT)
Table 63. APAC Quetiapine Fumarate Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Quetiapine Fumarate Sales Forecast by Country (2026-2031) & (MT)
Table 65. Europe Quetiapine Fumarate Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Quetiapine Fumarate Sales Forecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Quetiapine Fumarate Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Quetiapine Fumarate Sales Forecast by Type (2026-2031) & (MT)
Table 69. Global Quetiapine Fumarate Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Quetiapine Fumarate Sales Forecast by Application (2026-2031) & (MT)
Table 71. Global Quetiapine Fumarate Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. AstraZeneca Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 73. AstraZeneca Quetiapine Fumarate Product Portfolios and Specifications
Table 74. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. AstraZeneca Main Business
Table 76. AstraZeneca Latest Developments
Table 77. Intas Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 78. Intas Quetiapine Fumarate Product Portfolios and Specifications
Table 79. Intas Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Intas Main Business
Table 81. Intas Latest Developments
Table 82. TAPI Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 83. TAPI Quetiapine Fumarate Product Portfolios and Specifications
Table 84. TAPI Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. TAPI Main Business
Table 86. TAPI Latest Developments
Table 87. Accord Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 88. Accord Quetiapine Fumarate Product Portfolios and Specifications
Table 89. Accord Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Accord Main Business
Table 91. Accord Latest Developments
Table 92. Hexal Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 93. Hexal Quetiapine Fumarate Product Portfolios and Specifications
Table 94. Hexal Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95. Hexal Main Business
Table 96. Hexal Latest Developments
Table 97. Dr.Reddy's Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 98. Dr.Reddy's Quetiapine Fumarate Product Portfolios and Specifications
Table 99. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. Dr.Reddy's Main Business
Table 101. Dr.Reddy's Latest Developments
Table 102. Lupin Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 103. Lupin Quetiapine Fumarate Product Portfolios and Specifications
Table 104. Lupin Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Lupin Main Business
Table 106. Lupin Latest Developments
Table 107. Sun Pharmaceutical Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
Table 109. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. Sun Pharmaceutical Main Business
Table 111. Sun Pharmaceutical Latest Developments
Table 112. Hunan Dongting Pharm Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 113. Hunan Dongting Pharm Quetiapine Fumarate Product Portfolios and Specifications
Table 114. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. Hunan Dongting Pharm Main Business
Table 116. Hunan Dongting Pharm Latest Developments
Table 117. SuZhou NO.4 Phamaceutical Factory Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 118. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolios and Specifications
Table 119. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. SuZhou NO.4 Phamaceutical Factory Main Business
Table 121. SuZhou NO.4 Phamaceutical Factory Latest Developments
Table 122. Fuan Pharmaceutical Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 123. Fuan Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
Table 124. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. Fuan Pharmaceutical Main Business
Table 126. Fuan Pharmaceutical Latest Developments
Table 127. Zhejiang Supor Pharmaceuticals Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 128. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolios and Specifications
Table 129. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 130. Zhejiang Supor Pharmaceuticals Main Business
Table 131. Zhejiang Supor Pharmaceuticals Latest Developments
Table 132. Zhejiang Huahai Pharmaceutical Basic Information, Quetiapine Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 133. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolios and Specifications
Table 134. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 135. Zhejiang Huahai Pharmaceutical Main Business
Table 136. Zhejiang Huahai Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Quetiapine Fumarate
Figure 2. Quetiapine Fumarate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Quetiapine Fumarate Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Quetiapine Fumarate Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Quetiapine Fumarate Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Quetiapine Fumarate Sales Market Share by Country/Region (2024)
Figure 10. Quetiapine Fumarate Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immediate Release Tablets
Figure 12. Product Picture of Extended Release Tablets
Figure 13. Global Quetiapine Fumarate Sales Market Share by Type in 2025
Figure 14. Global Quetiapine Fumarate Revenue Market Share by Type (2020-2025)
Figure 15. Quetiapine Fumarate Consumed in Adult
Figure 16. Global Quetiapine Fumarate Market: Adult (2020-2025) & (MT)
Figure 17. Quetiapine Fumarate Consumed in Others
Figure 18. Global Quetiapine Fumarate Market: Others (2020-2025) & (MT)
Figure 19. Global Quetiapine Fumarate Sale Market Share by Application (2024)
Figure 20. Global Quetiapine Fumarate Revenue Market Share by Application in 2025
Figure 21. Quetiapine Fumarate Sales by Company in 2025 (MT)
Figure 22. Global Quetiapine Fumarate Sales Market Share by Company in 2025
Figure 23. Quetiapine Fumarate Revenue by Company in 2025 ($ millions)
Figure 24. Global Quetiapine Fumarate Revenue Market Share by Company in 2025
Figure 25. Global Quetiapine Fumarate Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Quetiapine Fumarate Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Quetiapine Fumarate Sales 2020-2025 (MT)
Figure 28. Americas Quetiapine Fumarate Revenue 2020-2025 ($ millions)
Figure 29. APAC Quetiapine Fumarate Sales 2020-2025 (MT)
Figure 30. APAC Quetiapine Fumarate Revenue 2020-2025 ($ millions)
Figure 31. Europe Quetiapine Fumarate Sales 2020-2025 (MT)
Figure 32. Europe Quetiapine Fumarate Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Quetiapine Fumarate Sales 2020-2025 (MT)
Figure 34. Middle East & Africa Quetiapine Fumarate Revenue 2020-2025 ($ millions)
Figure 35. Americas Quetiapine Fumarate Sales Market Share by Country in 2025
Figure 36. Americas Quetiapine Fumarate Revenue Market Share by Country (2020-2025)
Figure 37. Americas Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 38. Americas Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 39. United States Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Quetiapine Fumarate Sales Market Share by Region in 2025
Figure 44. APAC Quetiapine Fumarate Revenue Market Share by Region (2020-2025)
Figure 45. APAC Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 46. APAC Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 47. China Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 51. India Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Quetiapine Fumarate Sales Market Share by Country in 2025
Figure 55. Europe Quetiapine Fumarate Revenue Market Share by Country (2020-2025)
Figure 56. Europe Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 57. Europe Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 58. Germany Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 59. France Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Quetiapine Fumarate Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 66. Egypt Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Quetiapine Fumarate in 2025
Figure 72. Manufacturing Process Analysis of Quetiapine Fumarate
Figure 73. Industry Chain Structure of Quetiapine Fumarate
Figure 74. Channels of Distribution
Figure 75. Global Quetiapine Fumarate Sales Market Forecast by Region (2026-2031)
Figure 76. Global Quetiapine Fumarate Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Quetiapine Fumarate Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Quetiapine Fumarate Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Quetiapine Fumarate Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Quetiapine Fumarate Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Quetiapine Fumarate
Figure 2. Quetiapine Fumarate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Quetiapine Fumarate Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Quetiapine Fumarate Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Quetiapine Fumarate Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Quetiapine Fumarate Sales Market Share by Country/Region (2024)
Figure 10. Quetiapine Fumarate Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immediate Release Tablets
Figure 12. Product Picture of Extended Release Tablets
Figure 13. Global Quetiapine Fumarate Sales Market Share by Type in 2025
Figure 14. Global Quetiapine Fumarate Revenue Market Share by Type (2020-2025)
Figure 15. Quetiapine Fumarate Consumed in Adult
Figure 16. Global Quetiapine Fumarate Market: Adult (2020-2025) & (MT)
Figure 17. Quetiapine Fumarate Consumed in Others
Figure 18. Global Quetiapine Fumarate Market: Others (2020-2025) & (MT)
Figure 19. Global Quetiapine Fumarate Sale Market Share by Application (2024)
Figure 20. Global Quetiapine Fumarate Revenue Market Share by Application in 2025
Figure 21. Quetiapine Fumarate Sales by Company in 2025 (MT)
Figure 22. Global Quetiapine Fumarate Sales Market Share by Company in 2025
Figure 23. Quetiapine Fumarate Revenue by Company in 2025 ($ millions)
Figure 24. Global Quetiapine Fumarate Revenue Market Share by Company in 2025
Figure 25. Global Quetiapine Fumarate Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Quetiapine Fumarate Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Quetiapine Fumarate Sales 2020-2025 (MT)
Figure 28. Americas Quetiapine Fumarate Revenue 2020-2025 ($ millions)
Figure 29. APAC Quetiapine Fumarate Sales 2020-2025 (MT)
Figure 30. APAC Quetiapine Fumarate Revenue 2020-2025 ($ millions)
Figure 31. Europe Quetiapine Fumarate Sales 2020-2025 (MT)
Figure 32. Europe Quetiapine Fumarate Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Quetiapine Fumarate Sales 2020-2025 (MT)
Figure 34. Middle East & Africa Quetiapine Fumarate Revenue 2020-2025 ($ millions)
Figure 35. Americas Quetiapine Fumarate Sales Market Share by Country in 2025
Figure 36. Americas Quetiapine Fumarate Revenue Market Share by Country (2020-2025)
Figure 37. Americas Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 38. Americas Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 39. United States Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Quetiapine Fumarate Sales Market Share by Region in 2025
Figure 44. APAC Quetiapine Fumarate Revenue Market Share by Region (2020-2025)
Figure 45. APAC Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 46. APAC Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 47. China Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 51. India Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Quetiapine Fumarate Sales Market Share by Country in 2025
Figure 55. Europe Quetiapine Fumarate Revenue Market Share by Country (2020-2025)
Figure 56. Europe Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 57. Europe Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 58. Germany Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 59. France Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Quetiapine Fumarate Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Quetiapine Fumarate Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Quetiapine Fumarate Sales Market Share by Application (2020-2025)
Figure 66. Egypt Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Quetiapine Fumarate Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Quetiapine Fumarate in 2025
Figure 72. Manufacturing Process Analysis of Quetiapine Fumarate
Figure 73. Industry Chain Structure of Quetiapine Fumarate
Figure 74. Channels of Distribution
Figure 75. Global Quetiapine Fumarate Sales Market Forecast by Region (2026-2031)
Figure 76. Global Quetiapine Fumarate Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Quetiapine Fumarate Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Quetiapine Fumarate Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Quetiapine Fumarate Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Quetiapine Fumarate Revenue Market Share Forecast by Application (2026-2031)
